Time for a change of mind? Drugs like magic mushrooms and ecstasy are widely banned. But brain-altering drugs are showing promise in treating intractable mental health problems.

Last year, a treatment derived from party drug ketamine became the first new type of antidepressant to be approved in decades. London’s Imperial College and Baltimore-based Johns Hopkins opened psychedelic research centres, a sign that the subject is edging into the mainstream.

Continue Reading on Financial Review